Latest filings (excl ownership)
6-K
Share Purchase and Sale Agreement
20 Sep 24
6-K
Psyence Biomedical Ltd. Announces Receipt of Staff Delisting Determination from Nasdaq
13 Sep 24
6-K
Current report (foreign)
5 Sep 24
6-K
Current report (foreign)
30 Aug 24
424B3
Prospectus supplement
30 Aug 24
EFFECT
Notice of effectiveness
29 Aug 24
6-K
Current report (foreign)
20 Aug 24
F-1
Registration statement (foreign)
19 Aug 24
424B3
Prospectus supplement
19 Aug 24
EFFECT
Notice of effectiveness
16 Aug 24
POS AM
Prospectus update (post-effective amendment)
12 Aug 24
6-K
Common Stock Purchase Agreement
31 Jul 24
S-8
Registration of securities for employees
30 Jul 24
20-F
2024 FY
Annual report (foreign)
26 Jul 24
6-K
Current report (foreign)
24 Jul 24
6-K
Current report (foreign)
23 Jul 24
6-K
Psyence Biomedical Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
5 Jul 24
6-K
Current report (foreign)
20 Jun 24
6-K
Current report (foreign)
6 Jun 24
EFFECT
Notice of effectiveness
15 May 24
F-1/A
Registration statement (foreign) (amended)
6 May 24
F-1/A
Registration statement (foreign) (amended)
18 Apr 24
6-K
Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares
15 Mar 24
6-K
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
12 Mar 24
F-1
Registration statement (foreign)
9 Feb 24
20-F
2024 FY
Annual report (foreign)
31 Jan 24
CERT
Certification of approval for exchange listing
26 Jan 24
8-A12B
Registration of securities on exchange
25 Jan 24
425
Business combination disclosure
22 Jan 24
425
Business combination disclosure
17 Jan 24
425
Business combination disclosure
15 Nov 23
424B3
Prospectus supplement
15 Nov 23
SEC STAFF
SEC staff action: Order
15 Nov 23
F-4/A
Registration of securities (foreign) (amended)
13 Nov 23
F-4/A
Registration of securities (foreign) (amended)
13 Nov 23
CORRESP
Correspondence with SEC
13 Nov 23
EFFECT
Notice of effectiveness
13 Nov 23
F-4/A
Registration of securities (foreign) (amended)
3 Nov 23
CORRESP
Correspondence with SEC
3 Nov 23
UPLOAD
Letter from SEC
25 Oct 23
Latest ownership filings